Sangamo Therapeutics, Inc., a pioneering leader in gene-based medicine development, is excited to announce a significant funding milestone, having successfully raised $50 million in a recent financing round. This influx of capital will further propel Sangamo鈥檚 mission to transform the lives of patients suffering from serious genetic diseases through innovative therapeutic solutions. With a robust pipeline of clinical trials underway, including groundbreaking in vivo human genome editing studies, Sangamo is at the forefront of scientific advancement, harnessing cutting-edge technologies to address unmet medical needs. The new funds will be strategically allocated towards accelerating the development of current clinical programs as well as exploring new avenues for transformative gene therapies. As we push the boundaries of what is possible in genetic medicine, this funding will enable our talented team of scientists and researchers to enhance their efforts in discovering and developing next-generation medicines. At Sangamo, we believe that the potential for science to make a meaningful impact on patients' lives is limitless, and this funding marks a critical step in our journey toward groundbreaking treatments. For more information about our innovative approaches to gene therapy and to stay updated on our latest initiatives, we invite you to visit our website at www.sangamo.com.
Revolutionizing Gene Therapy: Sangamo Therapeutics Secures $50 Million in Funding
Recently funded 路 $50.0MHealthcare
Get the full Sangamo Therapeutics, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
